Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The Next $100 Billion Technology Business
Forbes
Thursday, December 30, 2010 - 11:14am
tags:
DNA sequencing
Novavax's Charts Look Healthy
TheStreet.com
Thursday, December 30, 2010 - 11:13am
tags:
Novavax
FDA Delay of MannKind's Inhaled Insulin Is Mostly Positive News
Seeking Alpha
Thursday, December 30, 2010 - 11:12am
tags:
MannKind, FDA, Afrezza, inhaled insulin
Seattle Genetics Looks Attractive on Fundamentals, Pipeline
Seeking Alpha
Thursday, December 30, 2010 - 11:07am
tags:
Seattle Genetics, cancer, monoclonal antibodies
Theravance Evenly Poised
Yahoo/Zacks.com
Thursday, December 30, 2010 - 10:59am
tags:
Theravance, GSK
ZIOP Initiates Cancer Study
Yahoo/Zacks.com
Thursday, December 30, 2010 - 10:58am
tags:
Ziopharm, cancer, palifosfamide, Allos
Sucampo buys Swiss patent-holding company
Bizjournals.com
Thursday, December 30, 2010 - 10:56am
tags:
Sucampo, M&A
FDA OKs Endo Pharmaceuticals' testosterone gel
Yahoo/AP
Thursday, December 30, 2010 - 10:55am
tags:
Endo, testosterone, FDA, Fortesta
The Painful Death of a Promising Drug Class
Motley Fool
Thursday, December 30, 2010 - 10:53am
tags:
Regeneron, Sanofi, JNJ, AstraZeneca, NGF-1
Pfizer buys Synbiotics for undisclosed amount
Yahoo/AP
Wednesday, December 29, 2010 - 5:59pm
tags:
animal health, Pfizer, Synbiotics, M&A
The Most Promising Dividends in Pharmaceuticals
Motley Fool
Wednesday, December 29, 2010 - 11:48am
tags:
dividends, Eli Lilly, GSK, Bristol-Myers Squibb, Pfizer, Merck, Abbott Laboratories, JNJ, Merdian, Sanofi, Novartis, AstraZeneca, Teva Pharmaceuticals, Novo Nordisk
Will Genomic Health's Next Quarter Be a Bomb?
Motley Fool
Wednesday, December 29, 2010 - 11:39am
tags:
Genomic Health
4-Star Stocks Poised to Pop: Novo Nordisk
Motley Fool
Wednesday, December 29, 2010 - 11:34am
tags:
Novo Nordisk
Impax gets FDA approval for generic antibiotic
Yahoo/AP
Wednesday, December 29, 2010 - 11:33am
tags:
generics, Impax, FDA, DORYX
Abbott the Only One Left in the Osteoarthritis Game
Seeking Alpha
Wednesday, December 29, 2010 - 11:28am
tags:
Abbott Laboratories, osteoarthritis, JNJ, AstraZeneca, Pfizer, Regeneron, Sanofi
DARA Biosciences Looks to Raise $4M
TheStreet.com
Wednesday, December 29, 2010 - 10:55am
tags:
DARA Biosciences
Aastrom Biosciences' Uptrend Fueled by More Than Just Market Momentum
Seeking Alpha
Wednesday, December 29, 2010 - 10:53am
tags:
Aastrom, Cell Therapeutics, StemCells
Savient Pharma starts search for new CEO
Yahoo/AP
Wednesday, December 29, 2010 - 10:51am
tags:
Pharma CEOs, Savient
GSK pitches Votrient rebate if trial favors Sutent
Fierce Pharma
Wednesday, December 29, 2010 - 10:50am
tags:
GSK, Sutent, Votrient, cancer
AstraZeneca's Brennan Poaches Pfizer to Rebuild Research
Bloomberg
Wednesday, December 29, 2010 - 10:47am
tags:
Pfizer, R&D, AstraZeneca, David Brennan, Pharma CEOs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.